Patents Assigned to Advancis Pharmaceutical Corporation
  • Multiple-delayed release antifungal product, use and formulation thereof
    Patent number: 7157095
    Abstract: An anti-fungal product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the anti-fungal product being reached in less than about twelve hours after initial release of anti-fungal from the product.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: January 2, 2007
    Assignee: Advancis Pharmaceutical Corporation
    Inventors: Edward M. Rudnic, James D. Isbister, Donald J. Treacy, Jr., Sandra E. Wassink
  • Antibiotic composition with inhibitor
    Patent number: 7122204
    Abstract: Antibiotic composition having four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor, followed by release of the antibiotic followed by release of the inhibitor. In a preferred embodiment, release from the second, third and fourth dosage forms is initiated after the component released from the immediately previous form reaches Cmax.
    Type: Grant
    Filed: April 21, 2003
    Date of Patent: October 17, 2006
    Assignee: Advancis Pharmaceutical Corporation
    Inventor: Edward M. Rudnic
  • Antineoplastic product, use and formulation thereof
    Patent number: 7108859
    Abstract: An antineoplastic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antineoplastic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
    Type: Grant
    Filed: October 21, 2002
    Date of Patent: September 19, 2006
    Assignee: Advancis Pharmaceutical Corporation
    Inventors: Edward M. Rudnic, James D. Isbister, Donald J. Treacy, Jr., Sandra E. Wassink
  • Multiple-delayed release anti-neoplastic product, use and formulation thereof
    Patent number: 7105174
    Abstract: An anti-neoplastic product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the anti-neoplastic product being reached in less than about twelve hours after initial release of anti-neoplastic from the product.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: September 12, 2006
    Assignee: Advancis Pharmaceutical Corporation
    Inventors: Edward M. Rudnic, James D. Isbister, Donald J. Treacy, Jr., Sandra E. Wassink
  • Multiple-delayed release anti-viral product, use and formulation thereof
    Patent number: 7074417
    Abstract: An anti-viral product is comprised of at least three delayed release dosage forms, each of which has a different release profile, with the Cmax for the anti-viral product being reached in less than about twelve hours after initial release of anti-viral from the product.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: July 11, 2006
    Assignee: Advancis Pharmaceutical Corporation
    Inventors: Edward M. Rudnic, James D. Isbister, Donald J. Treacy, Jr., Sandra E. Wassink